Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus

[1]  Gang Liu,et al.  Clinical analysis of 215 consecutive cases with fever of unknown origin , 2018, Medicine.

[2]  C. Fidler,et al.  Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes , 2016, Diabetes Therapy.

[3]  I. Shimomura,et al.  Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) , 2016, Diabetes Care.

[4]  L. Stojanovska,et al.  Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study , 2015, Vascular health and risk management.

[5]  J. G. García Santos,et al.  Carotid intima-media thickness and hemodynamic parameters: reproducibility of manual measurements with Doppler ultrasound. , 2015, Medical ultrasonography.

[6]  H. Itoh,et al.  Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial , 2015, PloS one.

[7]  K. Khunti,et al.  Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study , 2014, Diabetes Care.

[8]  R. Kawamori,et al.  Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery. , 2014, Endocrinology.

[9]  I. Shimomura,et al.  Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE) , 2014, Diabetology & Metabolic Syndrome.

[10]  E. Ortega,et al.  Vitamin C Further Improves the Protective Effect of Glucagon-Like Peptide-1 on Acute Hypoglycemia-Induced Oxidative Stress, Inflammation, and Endothelial Dysfunction in Type 1 Diabetes , 2013, Diabetes Care.

[11]  Young Seol Kim,et al.  Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes , 2013, Diabetes & metabolism journal.

[12]  T. Kondo,et al.  Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. , 2013, Endocrine journal.

[13]  A. Goto,et al.  Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis , 2013, BMJ.

[14]  M. Namba,et al.  Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus. , 2013, Endocrine journal.

[15]  W. L. Jin,et al.  Repetitive hypoglycaemia increases serum adrenaline and induces monocyte adhesion to the endothelium in rat thoracic aorta , 2011, Diabetologia.

[16]  R. Casamitjana,et al.  Repeated Episodes of Hypoglycemia as a Potential Aggravating Factor for Preclinical Atherosclerosis in Subjects With Type 1 Diabetes , 2010, Diabetes Care.

[17]  Mark Woodward,et al.  Severe hypoglycemia and risks of vascular events and death. , 2010, The New England journal of medicine.

[18]  A. Ertl,et al.  Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals , 2010, Diabetes Care.

[19]  D. Newby,et al.  Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation , 2010, Diabetes Care.

[20]  Michael E. Miller,et al.  The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.

[21]  J. Rosenstock,et al.  Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia , 2009, Diabetes, obesity & metabolism.

[22]  J. N. Fisher,et al.  Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.

[23]  A. Ertl,et al.  Effects of Intensive Therapy and Antecedent Hypoglycemia on Counterregulatory Responses to Hypoglycemia in Type 2 Diabetes , 2009, Diabetes.

[24]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[25]  S. Dejager,et al.  Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes , 2007, Diabetologia.

[26]  G. Thomson,et al.  Insulin-induced hypoglycemia induces a rise in C-reactive protein. , 2000, Diabetes care.

[27]  B. Frier,et al.  Leucocyte Mobilization and Release of Neutrophil Elastase Following Acute Insulin‐induced Hypoglycaemia in Normal Humans , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[28]  E. B. French,et al.  Peripheral blood cell changes in response to acute hypoglycaemia in man , 1983, European journal of clinical investigation.

[29]  S. Madsbad,et al.  Changes in Platelet Function, Blood Coagulation and Fibrinolysis During Insulin-Induced Hypoglycaemia in Juvenile Diabetics and Normal Subjects , 1982, Thrombosis and Haemostasis.

[30]  M. Sata,et al.  Inflammatory Biomarkers and Atherosclerosis. , 2016, International heart journal.

[31]  S. Schinner Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[32]  S. Schinner Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes , 2009 .

[33]  Teven,et al.  MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .

[34]  J. Smith,et al.  Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. , 1992, Hormone and metabolic research. Supplement series.